切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2013, Vol. 02 ›› Issue (01) : 34 -38. doi: 10.3877/cma.j.issn.2095-3232.2013.01.008

所属专题: 文献

临床研究

肝细胞肝癌合并原发性胃部非霍奇金淋巴瘤的诊治特点
姚志成1, 刘波1, 李明亮2, 颜见3, 钟跃思3, 邓美海3,()   
  1. 1. 510530 广州,中山大学附属第三医院岭南医院普通外科
    2. 510530 广州,中山大学附属第三医院岭南医院重症监护室
    3. 中山大学附属第三医院肝胆外科
  • 收稿日期:2012-12-07 出版日期:2013-02-10
  • 通信作者: 邓美海
  • 基金资助:
    广东省科技计划项目(2010B031600215)

Characteristic of diagnosis and treatment of hepatocellular carcinoma complicated with primary gastric non-Hodgkin’s lymphoma: a case report

Zhi-cheng YAO1, Bo LIU1, Ming-liang LI2, Jian YAN3, Yue-si ZHONG3, Mei-hai DENG3,()   

  1. 1. Department of General Surgery, Lingnan Hospital, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510530, China
  • Received:2012-12-07 Published:2013-02-10
  • Corresponding author: Mei-hai DENG
  • About author:
    Corresponding author: DENG Mei-hai, Email:
引用本文:

姚志成, 刘波, 李明亮, 颜见, 钟跃思, 邓美海. 肝细胞肝癌合并原发性胃部非霍奇金淋巴瘤的诊治特点[J]. 中华肝脏外科手术学电子杂志, 2013, 02(01): 34-38.

Zhi-cheng YAO, Bo LIU, Ming-liang LI, Jian YAN, Yue-si ZHONG, Mei-hai DENG. Characteristic of diagnosis and treatment of hepatocellular carcinoma complicated with primary gastric non-Hodgkin’s lymphoma: a case report[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2013, 02(01): 34-38.

目的

探讨肝细胞肝癌(肝癌)合并原发性胃部非霍奇金淋巴瘤(PGNHL)的诊治特点。

方法

回顾性研究2006年10月中山大学附属第三医院收治的1例肝癌合并PGNHL患者。患者已签署知情同意书,符合医学伦理学规定。分析其病史、诊治经过、治疗方法、疗效和血常规、肝功能、病毒血清学、腹部超声、计算机体层摄影术(CT)和电子胃镜等临床资料,总结该病诊治特点。

结果

该例患者男性,76岁,因进行性疲劳并食欲减退1个月入院。既往有30年的乙型肝炎病毒(HBV)感染史。术前腹部超声及CT检查结果均考虑胃癌肝转移,电子胃镜检查示胃腔内巨大肿块,活体组织检查(活检)示低分化腺癌。入院后经积极术前准备在气管插管全身麻醉下行全胃、肝左外叶、脾切除以及胰尾部肿瘤根治性切除术。术后病理检查示胃部弥漫性大B细胞淋巴瘤、肝脏中分化肝癌。术后给予化学药物治疗(化疗)。出院后随访67个月,无复发征象。

结论

该例肝癌合并PGNHL的发生可能与HBV长期感染密切相关,无特征性临床表现,诊断主要靠病理学确诊。根治性切除手术是延长患者长期生存期的重要手段。

Objective

To explore the characteristic of diagnosis and treatment of hepatocellular carcinoma (HCC) complicated with primary gastric non-Hodgkin’s lymphoma(PGNHL).

Methods

Retrospective analysis was performed in one patient who was diagnosed with HCC complicated with PGNHL in the Third Affiliated Hospital of Sun Yat-sen University in October 2006. Local ethical committee approval had been received and that the informed consent of the subject was obtained. The clinical data including case history, treatment procedures, efficacy, blood routine, liver function, viral serology, abdominal ultrasound, abdominal computed tomography(CT), electronic gastroscopy examination as well as treatment were analyzed and the treatment characteristics were summarized.

Results

The patient (male,76 years old) was admitted in hospital for progressive fatigue and loss of appetite with a 30-year hepatitis B virus infection history. Both preoperative abdominal ultrasound and CT indicated gastric cancer with liver metastasis. The electronic gastroscope test showed huge mass in the gastral cavity. The biopsy indicated poorly differentiated adenocarcinoma. The patient underwent total gastrectomy and resection of all metastasis including left lateral lobe of liver, spleen and the tail of pancreas. The postoperative pathological examination demonstrated two different pathological types: gastric diffuse large B-cell lymphoma and moderately-differentiated HCC. The patient received chemotherapy and was followed up for 67 months after the operation. No recurrence was observed.

Conclusions

HCC complicated with PGNHL is rare and might be closely related to the long-term hepatitis B virus(HBV) infection. Patients with HCC and PGNHL have no specific clinical manifestations. The diagnosis is confirmed by pathological examination. Radical resection is the preferred treatment for better prgonosis.

图1 肝细胞肝癌合并原发性胃部非霍奇金淋巴瘤患者的术前腹部超声检查图像
图2 肝细胞肝癌合并原发性胃部非霍奇金淋巴瘤患者的术前腹部CT扫描图像
图3 肝细胞肝癌合并原发性胃部非霍奇金淋巴癌患者手术切除大体标本
图4 肝细胞肝癌合并原发性胃部非霍奇金淋巴癌患者手术切除物的病理检查(HE,×200)
表1 PubMed数据库中肝癌并发NHL病例一览表
[1]
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12):2893-2917.
[2]
El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 2012, 142(6):1264-1273.
[3]
Amin J, Dore GJ, O’Connell DL, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol, 2006, 45(2):197-203.
[4]
Marcucci F, Mele A, Spada E, et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin’s lymphoma. Haematologica, 2006, 91(4):554-557.
[5]
Kim JH, Bang YJ, Park BJ, et al. Hepatitis B virus infection and B-cell non-Hodgkin’s lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res, 2002, 93(5):471-477.
[6]
Bosch FX, Ribes J, Díaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology, 2004, 127(5 Suppl 1):S5-S16.
[7]
Ennibi K, Mikdame M, Rabhi M, et al. Primary gastric lymphoma: a retrospective series of 35 cases. Tunis Med(法文), 2008, 86(5):457-462.
[8]
Müller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol, 2005, 84(1):1-12.
[9]
Cavanna L, Civardi G, Fornari F, et al. Simultaneous relapse of liver cell carcinoma and non-Hodgkin’s lymphoma in the liver. report of a case with diagnosis by ultrasonically guided fine needle aspiration biopsy. Acta Cytol, 1994, 38(3):451-454.
[10]
Shikuwa S, Ito M, Nakashima M, et al. Autopsy case of colocalized tumors of hepatocellular carcinoma and malignant lymphoma. J Gastroenterol, 1996, 31(1):129-132.
[11]
Suriawinata A, Ye MQ, Emre S, et al. Hepatocellular carcinoma and non-Hodgkin lymphoma in a patient with chronic hepatitis C and cirrhosis. Arch Pathol Lab Med, 2000, 124(10):1532-1534.
[12]
Takeshima F, Kunisaki M, Aritomi T, et al. Hepatic mucosa-associated lymphoid tissue lymphoma and hepatocellular carcinoma in a patient with hepatitis B virus infection. J Clin Gastroenterol, 2004, 38(9):823-826.
[13]
Kataoka TR, Tsukamoto Y, Kanazawa N, et al. Concomitant hepatocellular carcinoma and non-Hodgkin’s lymphoma in a patient with nodular regenerative hyperplasia. Pathol Int, 2006, 56(5):279-282.
[14]
Himoto T, Miyauchi Y, Nomura K, et al. Coexistence of splenic non-Hodgkin’s lymphoma with hepatocellular carcinoma in a patient with chronic hepatitis C. Dig Dis Sci, 2006, 51(1):70-76.
[15]
Ohtsubo K, Oku E, Imamura R, et al. Simultaneous hepatic relapse of non-Hodgkin’s lymphoma and hepatocellular carcinoma in a patient with hepatitis C virus-related cirrhosis. Acta Haematol, 2006, 116(4):266-271.
[16]
Lin A, Kadam JS, Bodenheimer HC, et al. Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases. J Med Virol, 2008, 80(8):1350-1353.
[17]
Utsunomiya T, Okamoto M, Tsujita E, et al. Hepatocellular carcinoma infiltrated with non-Hodgkin’s lymphoma: report of a case. Surg Today, 2009, 39(11):1010-1012.
[18]
Heidecke S, Stippel DL, Hoelscher AH, et al. Simultaneous occurrence of a hepatocellular carcinoma and a hepatic non-Hodgkin’s lymphoma infiltration. World J Hepatol, 2010, 2(6):246-250.
[19]
Chong VH, Idros A, Telisinghe PU. Triple synchronous gastrointestinal malignancies: a rare occurrence. Singapore Med J,2010, 51(10):e176-e177.
[1] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[2] 王兴, 张峰伟. 腹腔镜肝切除联合断面射频消融治疗伴微血管侵犯肝细胞癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 580-583.
[3] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[4] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[5] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[6] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[7] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[8] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[9] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[10] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[11] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[12] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
[13] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
[14] 张海涛, 贾哲, 马超, 张其坤, 武聚山, 郭庆良, 曾道炳, 栗光明, 王孟龙. 手术切除与射频消融治疗血管周围型单发小肝癌临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 523-527.
[15] 吕瑶, 张婵, 陈建华, 张鸣青. 压力控制容量保证通气模式在腹腔镜肝细胞癌切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 528-533.
阅读次数
全文


摘要